Facebook
Twitter
LinkedIn
ForwardSevere Asthma Exacerbations: Mechanisms, Sequelae and Management
This course is part of the 2017 Virtual Annual Meeting. Want more virtual meeting recordings? Save by ordering the full set!
Session 2101 from the 2017 AAAAI Annual Meeting focuses on the concept of asthma exacerbation. The practicing allergist, whether managing pediatric or adult populations, must understand evolving concepts in the pathophysiology underlying exacerbations, the physiologic sequelae thereof, and how best to both prevent and manage these. New insights into the mechanisms of these exacerbations have been gained recently, as environmental, infectious and genetic factors interact.
AMA PRA Category 1 Credits™: 1.50
CE: 1.50
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the mechanisms underlying asthma exacerbation
- Describe physiologic consequences of asthma exacerbation
- Identify prevention and treatment modalities for exacerbations
Faculty
Dr. Nizar N. Jarjour, MD
University of Wisconsin and Public Health, Madison, WI
Relevant relationships: consulting AstraZeneca
Dr. Paul M. O'Byrne, MD FAAAAI
Department of Medicine, Cardio-Respiratory Research Group, McMaster University, Hamilton, ON, Canada
Relevant relationships: Research Grant: Omalizumab, AstraZeneca (Ongoing). Advisory board: Consulting (Ongoing): AstraZeneca, Boehringer, GSK, Medimmune, Peptinovate.
Reviewers
Karen Gregory, DNP APRN-BC RRT AE-C
Oklahoma Allergy and Asthma Clinic, Edmond, OK
Relevant relationships: Merck, MEDA and Novartis: speakers bureau
Thomas Miller, MD FAAAAI
Allergy Associates of Western Michigan, Grandville, MI
Relevant relationships: Patent holder for new pulmonary function device
Kevin Parks, MD FAAAAI
AAC/CRI of Southern Oregon, Medford, OR
Relevant relationships: None
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.50 Contact Hours.
Medium and Method of Physician Participation for an Enduring Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME and Disclosure information.
- Complete all required components.
- Complete the post-test. You must achieve a score of 70% or higher on post-tests to claim credit.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Release date
Original release date: June 1, 2017. Valid for credit through May 31, 2019.
Questions
Activity-related questions should be directed to cme@aaaai.org
Available Credit
- 1.50 AttendanceAttendance credit.
- 1.50 CECE credit.
- 1.50 CMECME credit.